Synthesis and application of (18F) fluorodeoxyglucose in oncology diagnosis

Synthesis and application of (18F) fluorodeoxyglucose in oncology diagnosis

[18F] Fluorodeoxyglucose ([18F] FDG) is the most commonly used radiopharmaceutical in clinical positron emission tomography (PET) in oncology. Cancer cells create their own specific microenvironment to survive and grow. Specific tumor microenvironment contributes to cancer metabolic reprogramming. T...

Full description

Bibliographic Details
Main Authors:	Mateusz Wędrowski, Paweł Waśniowski, Ewelina Wędrowska, Elżbieta Piskorska, Jolanta Czuczejko, Bogdan Małkowski, Walery Żukow
Format:	Article
Language:	English
Published:	Kazimierz Wielki University 2017-12-01
Series:	Journal of Education, Health and Sport
Subjects:	synthesis [18f] fdg, glucose metabolism, [18f] fdg metabolism, positron emission tomography.
Online Access:	http://www.ojs.ukw.edu.pl/index.php/johs/article/view/5245

Similar Items

The emerging role of whole-body 18F-fluorodeoxyglucose positron emission tomography in patients with sarcoidosis
by: Silvia Taralli, et al.
Published: (2012-01-01)

Quantitative FDG PET Assessment for Oncology Therapy
by: Kenji Hirata, et al.
Published: (2021-02-01)

Case report: Evaluation of hindlimb ischemia using 18F-fluorodeoxyglucose positron emission tomography in a cat with cardiogenic arterial thromboembolism
by: Hyeongyeong Lee, et al.
Published: (2023-09-01)

Aging and Cerebral Glucose Metabolism: <sup>18</sup>F-FDG-PET/CT Reveals Distinct Global and Regional Metabolic Changes in Healthy Patients
by: Robert Christopher Subtirelu, et al.
Published: (2023-10-01)

Automatic Production of [<sup>18</sup>F]F-DOPA Using the Raytest SynChrom R&D Module
by: Paweł Waśniowski, et al.
Published: (2022-12-01)

Physiological myocardial 18F-FDG uptake pattern in oncologic PET/CT: comparison with findings in cardiac sarcoidosis
by: Takashi Norikane, et al.
Published: (2024-01-01)

If It Works, Don’t Touch It? A Cell-Based Approach to Studying 2-[<sup>18</sup>F]FDG Metabolism
by: Eva-Maria Klebermass, et al.
Published: (2021-09-01)

Influence of key histological characteristics on 18F-fluorodeoxyglucose /18F-choline positron emission tomography positivity in hepatocellular carcinoma: A machine learning study
by: Jérôme Ghidaglia, et al.
Published: (2023-01-01)

Estimation of dose distribution in occupationally exposed individuals to FDG-18F
by: Isabelle Viviane Batista de Lacerda, et al.
Published: (2015-05-01)

Frequency and Clinical Significance of Incidental Prostatic FDG uptake in FDG PET imaging
by: Elif Özdemir, et al.
Published: (2020-06-01)

The role of 18F-FDG PET/CT in evaluation of Primary CNS lymphoma: The path less travelled
by: Sharjeel Usmani, et al.
Published: (2023-07-01)

The value of 18F-FDG PET/CT imaging in breast cancer staging
by: Ulkem Yararbas, et al.
Published: (2018-02-01)

Intracranial Leptomeningeal Carcinomatosis: A Diagnostic Study with 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography
by: Susanna Nuvoli, et al.
Published: (2018-02-01)

Clinical Utility of <sup>18</sup>Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (<sup>18</sup>F-FDG PET/CT) in Multivisceral Transplant Patients
by: Shao Jin Ong, et al.
Published: (2023-06-01)

Performance characteristics of 18F–fluorodeoxyglucose in non-infected hip replacement
by: Yiqun Wang, et al.
Published: (2023-01-01)

Optimal timing of interictal FDG‐PET for epilepsy surgery: A systematic review on time since last seizure
by: Nienke N. deLaat, et al.
Published: (2022-09-01)

Evaluation of blood supply and metabolism in tumor, axillary lymph node and normal breast tissue with F-18 FDG PET/CT in breast cancer: comparison with pathological prognostic factors
by: Ummuhan Abdulrezzak, et al.
Published: (2024-01-01)

Brain laterality evaluated by F-18 fluorodeoxyglucose positron emission computed tomography in autism spectrum disorders
by: Keattichai Keeratitanont, et al.
Published: (2022-08-01)

Diagnostic accuracy of fluorine-18 fluorodeoxyglucose positron emission tomography for suspected primary and postoperative pyogenic spondylitis
by: Qingyu Zhang, et al.
Published: (2023-01-01)

Factores que influenciam a estabilidade da 18F-FDG
by: Ana Graça, et al.
Published: (2011-05-01)

Whole-body metabolic connectivity framework with functional PET
by: Murray Bruce Reed, et al.
Published: (2023-05-01)

In vivo PET of synaptic density as potential diagnostic marker for cognitive disorders: prospective comparison with current imaging markers for neuronal dysfunction and relation to symptomatology - study protocol
by: Greet Vanderlinden, et al.
Published: (2024-02-01)

Evaluation of intramural hematoma: a novel use of 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging
by: Fan Yang, et al.
Published: (2024-03-01)

Vessel Wall Inflammatory Activity as Determined by F-18 Fluorodeoxyglucose PET in Large Vessel Vasculitis Is Attenuated by Immunomodulatory Drugs
by: Romilda Sherzay, et al.
Published: (2021-06-01)

Role of 18F-choline and 18F-fluorodeoxyglucose positron emission tomography in combination with magnetic resonance imaging in brachytherapy planning for locally advanced cervical cancer: A pilot study
by: Fadoua Rais, et al.
Published: (2023-07-01)

A new method for chemical & radiochemical purification of enriched water used in production [18F] FDG in Iran
by: P. Ashtari, et al.
Published: (2021-12-01)

Exercise Modifies the Brain Metabolic Response to Chronic Cocaine Exposure Inhibiting the Stria Terminalis
by: Colin Hanna, et al.
Published: (2023-12-01)

Brain Mapping the Effects of Chronic Aerobic Exercise in the Rat Brain Using FDG PET
by: Colin Hanna, et al.
Published: (2022-05-01)

Correlation between 18F-FDG Positron-Emission Tomography 18F-FDG Uptake Levels at Diagnosis and Histopathologic and Immunohistochemical Factors in Patients with Breast Cancer
by: Gamze Uğurluer, et al.
Published: (2016-07-01)

Correlation analysis between 18F-fluorodeoxyglucose positron emission tomography and cognitive function in first diagnosed Parkinson’s disease patients
by: Sun Zhihui, et al.
Published: (2023-06-01)

Correlation between EGFR mutation status and F18‐fluorodeoxyglucose positron emission tomography‐computed tomography image features in lung adenocarcinoma
by: Lei Zhu, et al.
Published: (2019-04-01)

Advances in the application of 18F-FDG PET/CT radiomics for diagnosis, treatment and prognosis prediction of lymphoma
by: CHENG Ran, et al.
Published: (2023-06-01)

18F-FDG PET/MRI and 18F-FDG PET/CT for the Management of Gynecological Malignancies: A Comprehensive Review of the Literature
by: Leila Allahqoli, et al.
Published: (2023-10-01)

18F-FDG positron emission tomography in the diagnosis and staging of marginal zone non-Hodgkin lymphomas
by: M. M. Khodzhibekova, et al.
Published: (2016-02-01)

Dosimetric evaluation of extremities in 18F-FDG PET/CT procedure using Monte Carlo Geant4 code
by: Paula Rocha Pessanha, et al.
Published: (2019-10-01)

IPET-CT in inflammatory diseases of kidneys and bladder: diagnostic efficacy
by: V. B. Berdichevsky, et al.
Published: (2021-12-01)

PROGNOSTIC VALUE OF 18F-FDG POSITRON EMISSION TOMOGRAPHY IN THE EARLY EVALUATION OF THE EFFICIENCY OF TREATMENT IN PATIENTS WITH NON-HODGKIN LYMPHOMAS
by: M. M. Khodzhibekova, et al.
Published: (2016-02-01)

Factors that influence the stability of the FDG
by: Ana Graça, et al.
Published: (2015-11-01)

Comparing the diagnostic efficacy of [18F]FDG PET/CT and [18F]FDG PET/MRI for detecting bone metastases in breast cancer: a meta-analysis
by: Xia Longjie, et al.
Published: (2023-07-01)

The role of (18F)-fluoro-D-glucose positron emission tomography/computed tomography in the surveillance of abnormal myocardial energy metabolism and cardiac dysfunction in a rat model of cardiopulmonary resuscitation
by: Liming Pan, et al.
Published: (2023-05-01)